ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Grisnilimab (anti-CD7) 是一种单克隆抗体 (抗 CD7)，是参与 Wilms' tumor 病因学的肿瘤抑制因子。Grisnilimab (anti-CD7) 调节多种靶基因的转录，并可能参与 RNA 的转录后处理。
Grisnilimab (anti-CD7), a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab (anti-CD7) regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA.
Grisnilimab (anti-CD7) (Ab191904) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD7 with Grisnilimab (anti-CD7) (Ab191904) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).
Grisnilimab (anti-CD7) (Ab191904) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD7 (red) with Grisnilimab (anti-CD7) (Ab191904) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.
Grisnilimab (anti-CD7) (Ab191904) - ELISA
Immobilized Recombinant huCD7-ECD-His protein at 2.0 μg/mL can bind Grisnilimab (anti-CD7) (Ab191904) with the EC50 of 25.54 ng/mL.
Grisnilimab (anti-CD7) (Ab191904) - SEC
The purity of Grisnilimab (anti-CD7) (Ab191904) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 ZJ24F1013088 |
分析证书 | Ab191904 |
| ZJ24F1013089 |
分析证书 | Ab191904 |
| ZJ24F1013090 |
分析证书 | Ab191904 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Low Endotoxin 级别指南 → 查看 Azide Free 级别指南 →
危险品化学品经营许可证（带存储）